The Marchand Institute is pleased to announce that their breakthrough paper, “A Systematic Review and Meta-Analysis of Intraperitoneal Bupivacaine in Laparoscopic Gynecologic Surgery” has been published in this month’s Journal of Pain Research. We are extremely excited about this new paper and the strong evidence it presents for the instillation of bupivacaine in the abdominal…
We are very pleased to report that our latest paper, “A Systematic Review and Meta-Analysis of the Effect of Intraoperative Bupivacaine in Gynaecologic Surgery After 24 Hours or 9 Half-lives” has been published in the prestigious Journal of Obstetrics and Gynecology of Canada, and also appears online in the US government’s “Pubmed” website. We look…
Although drug and surgical device patents are extremely common in the United States, actually patenting a surgical procedure is quite rare. This is largely because Federal Law prohibits any enforcement of patent infringement on surgical procedures under 35 U.S.C. § 287(c). Dr. Gregory Marchand received final approval this month of a very rare type of…
To compliment our already existing fellowship program, as well as enhance our surgical research and compliment our educational programs for medical students and residents, we are very excited to announce the completion of our Simulation Laboratory. This is the most advanced Surgical Simulation Laboratory in the USA incorporating both advanced laparoscopic and robotic simulators. Although…